CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial.

Bates A, Rushbrook S, Shapiro E, Grocott M, Cusack R

Open source

DOI
10.1186/s13063-020-04805-1
Published
2020 Nov 17
Container
Trials
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-020-04805-1,
  title = {CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial.},
  author = {Bates A and Rushbrook S and Shapiro E and Grocott M and Cusack R},
  year = {2020},
  journal = {Trials},
  doi = {10.1186/s13063-020-04805-1},
  url = {https://doi.org/10.1186/s13063-020-04805-1}
}

RIS

TY  - JOUR
TI  - CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial.
AU  - Bates A
AU  - Rushbrook S
AU  - Shapiro E
AU  - Grocott M
AU  - Cusack R
PY  - 2020
JO  - Trials
DO  - 10.1186/s13063-020-04805-1
UR  - https://doi.org/10.1186/s13063-020-04805-1
ER  - 

APA

A, B., S, R., E, S., M, G., & R, C. (2020). CovEMERALD: Assessing the feasibility and preliminary effectiveness of remotely delivered Eye Movement Desensitisation and Reprocessing following Covid-19 related critical illness: A structured summary of a study protocol for a randomised controlled trial.. Trials. https://doi.org/10.1186/s13063-020-04805-1

Source records